Selective Dimerization of Ethylene to 1-Butene with a Porous Catalyst

被引:198
作者
Metzger, Eric D. [1 ]
Brozek, Carl K. [1 ]
Comito, Robert J. [1 ]
Dinca, Mircea [1 ]
机构
[1] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA
关键词
PANCREATIC ALPHA-AMYLASE; ANGSTROM RESOLUTION; STARCH DIGESTION; INHIBITOR; HYPERGLYCEMIA; TENDAMISTAT; PEPTIDES; ACARBOSE; UPDATE;
D O I
10.1021/acscentsci.6b00012
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Current heterogeneous catalysts lack the fine steric and electronic tuning required for catalyzing the selective dimerization of ethylene to 1-butene, which remains one of the largest industrial processes still catalyzed by homogeneous catalysts. Here, we report that a metal-organic framework catalyzes ethylene dimerization with a combination of activity and selectivity for 1-butene that is premier among heterogeneous catalysts. The capacity for mild cation exchange in the material MFU-4l (MFU-4l = Zn5Cl4(BTDD)(3), H2BTDD = bis(1H-1,2,3-triazolo[4,5-b],[4',5'-i])dibenzo[1,4]dioxin) was leveraged to create a well-defined and site-isolated Ni(II) active site bearing close structural homology to molecular tris-pyrazolylborate complexes. In the presence of ethylene and methylaluminoxane, the material consumes ethylene at a rate of 41,500 mol per mole of Ni per hour with a selectivity for 1-butene of up to 96.2%, exceeding the selectivity reported for the current industrial dimerization process.
引用
收藏
页码:148 / 161
页数:14
相关论文
共 42 条
[1]   An update on the etiology and epidemiology of diabetes mellitus [J].
Adeghate, Ernest ;
Schattner, Peter ;
Dunn, Earl .
DIABETES MELLITUS AND ITS COMPLICATIONS: MOLECULAR MECHANISMS, EPIDEMIOLOGY, AND CLINICAL MEDICINE, 2006, 1084 :1-29
[2]   Type 2 diabetes: an epidemic disease in childhood [J].
Aye, T ;
Levitsky, LL .
CURRENT OPINION IN PEDIATRICS, 2003, 15 (04) :411-415
[3]  
Baron AD, 1998, DIABETES RES CLIN PR, V40, pS51
[4]   ASSIGNMENT OF ALL 4 DISULFIDE BRIDGES IN ECHISTATIN [J].
BAUER, M ;
SUN, YP ;
DEGENHARDT, C ;
KOZIKOWSKI, B .
JOURNAL OF PROTEIN CHEMISTRY, 1993, 12 (06) :759-764
[5]   EFFECT OF A PURIFIED AMYLASE INHIBITOR ON CARBOHYDRATE-METABOLISM AFTER A MIXED MEAL IN HEALTHY HUMANS [J].
BOIVIN, M ;
ZINSMEISTER, AR ;
GO, VLW ;
DIMAGNO, EP .
MAYO CLINIC PROCEEDINGS, 1987, 62 (04) :249-255
[6]   GASTROINTESTINAL AND METABOLIC EFFECTS OF AMYLASE INHIBITION IN DIABETICS [J].
BOIVIN, M ;
FLOURIE, B ;
RIZZA, RA ;
GO, VLW ;
DIMAGNO, EP .
GASTROENTEROLOGY, 1988, 94 (02) :387-394
[7]   THE STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE AT 1.8 ANGSTROM RESOLUTION AND COMPARISONS WITH RELATED ENZYMES [J].
BRAYER, GD ;
LUO, YG ;
WITHERS, SG .
PROTEIN SCIENCE, 1995, 4 (09) :1730-1742
[8]   Human α-amylase and starch digestion: An interesting marriage [J].
Butterworth, Peter J. ;
Warren, Frederick J. ;
Ellis, Peter R. .
STARCH-STARKE, 2011, 63 (07) :395-405
[9]  
Copeland R.A., 2002, Enzymes: A practical introduction to structure, mechanism, and data analysis, Vsecond
[10]  
Dieffenbach CWD., 2003, PCR Primer: A Laboratory Manual